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Abstract The subcellular distribution of Dp71 isoforms alter-
natively spliced for exon 71 and/or 78 was examined. The cDNA
sequence of each variant was fused to the C-terminus of the green
fluorescent protein and the constructs were transfected transi-
ently in the cell lines HeLa, C2C12 and N1E-115. The
subcellular distribution of the fused proteins was determined by
confocal microscope analysis. The Dp71 isoform lacking the
amino acids encoded by exons 71 and 78 was found exclusively in
the cytoplasm whereas the variants containing the amino acids
encoded by exon 71 and/or exon 78 show a predominant nuclear
localization. The nuclear localization of Dp71 provides a new
clue towards the establishment of its cellular function. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Duchenne muscular dystrophy is an X-linked recessive dis-
order caused by mutations in the dystrophin gene located on
the short arm of the chromosome at Xp21 [1]. Dystrophin is a
427 kDa (Dp427) rod-shaped protein consisting of four major
domains: an N-terminal actin-binding domain, a large region
of 24 spectrin-like triple helix repeats, a cysteine-rich region
and a C-terminal domain [2^4]. The N-terminal domain binds
to cytoplasmic actin while the cysteine-rich and C-terminal
domains region are important for Dp427 interaction with a
complex of transmembrane glycoproteins and cytoplasmic
factors know collectively as the dystrophin-associated protein
complex (DAPC) [5^7]. One protein of the complex, K-dys-
troglycan, has been shown to interact with the extracellular
matrix protein, merosin [8]. Thus one of the proposed func-
tions of Dp427 is to provide a structural link between the
actin cytoskeleton, the sarcolemma, and the extracellular ma-
trix.
The dystrophin gene is transcribed from at least seven dif-
ferent promoters located in di¡erent regions of the gene. Four
of these promoters are located within introns and encode
short dystrophin isoforms, named according to their molecu-
lar weight. There are three full-length dystrophins (Dp427)
which contain unique N-termini fused to the actin-binding,
rod, cysteine-rich and C-terminal domains [9,10]. Three dys-
trophin isoforms (Dp260, Dp140 and Dp116) lack the actin-
binding domain, but contain a portion of the rod domain and
retain the cysteine-rich and C-terminal domains [11^13]. The
remaining isoform Dp71 has a unique seven residues N-termi-
nus fused to the cysteine-rich and C-terminal domains [14,15].
Dp71 expression is regulated by a housekeeping type pro-
moter located in intron 62 of the gene [16], which results in
a wide variety of tissues containing this protein. It is present
in brain, retina, lung, liver, testis, kidney and smooth muscle,
and at low levels in fetal skeletal and cardiac muscle [17].
Recent reports have showed association of Dp71 with pro-
teins of the DAPC such as L-dystroglycan [18], dystrobrevin
[19] and syntrophin [20], however, Dp71 cannot functionally
substitute for the full-length dystrophin. Although the expres-
sion of Dp71 in muscle of mdx transgenic mice restores the
levels of dystrophin-associated proteins, it is not su⁄cient to
alleviate symptoms of muscle degeneration [21,22]. This indi-
cates that Dp71 is capable of interacting with the DAPC in a
similar manner as dystrophin, but binding to the membrane
per se is not su⁄cient to perform all the functional roles of
dystrophin.
A further complication in the study of Dp71 function was
raised from the identi¢cation of two alternative splicing sites
within the 3P end of its coding region, which involved exons
71 and 78 [23]. While the loss of exon 71 does not change the
reading frame of the transcript, the loss of exon 78 does,
resulting in the 13 C-terminal amino acids of dystrophin being
replaced by 31 new amino acids with hydrophobic properties
in the Dp71 protein product. The expression levels and the
ratio of the alternatively spliced isoforms of Dp71 vary largely
among the human adult tissues [23] and during the human
neural development [24].
As a ¢rst step in understanding the functional meaning of
Dp71 alternative splicing, we examined the subcellular distri-
bution of the di¡erent Dp71 splicing isoforms expressed as
fusion proteins with green £uorescent protein (GFP). We re-
port that alternative splicing determines the nuclear or cyto-
plasmic distribution of Dp71. The Dp71 isoform lacking the
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amino acids encoded by exons 71 and 78 was found exclu-
sively in the cytoplasm whereas the variants containing the
amino acids encoded by exon 71 and/or exon 78 show a pre-
dominant nuclear localization. These results indicate that al-
ternative splicing of Dp71 modulates its subcellular localiza-
tion and that the amino acids encoded by either exon 71 or
exon 78 participate in the nuclear transport of Dp71.
2. Materials and methods
2.1. Plasmid constructions
To generate GFP-Dp71 fusion proteins, cDNA clones correspond-
ing to Dp71 isoforms alternatively spliced out for exon 71 and/or exon
78 [23] were digested with EcoRI and subcloned in the correct reading
frame into the EcoRI site of the expression vector pQBI25 (Quantum
Biotechnologies Inc.). The resulting plasmids contained Dp71 cDNAs
fused to the C-terminus of GFP (Fig. 1) and are under the control of
the cytomegalovirus promoter. All constructs were veri¢ed by restric-
tion enzymes digest analysis and sequencing.
2.2. Cell cultures
HeLa cells were grown in Dulbecco’s modi¢ed Eagle medium
(DMEM) supplemented with 10% neonatal serum, 25 U/ml penicillin
and 25 Wg/ml streptomycin. C2C12 cells were grown in DMEM sup-
plemented with 10% fetal bovine serum, 25 U/ml penicillin, 25 Wg/ml
streptomycin and 1 mM sodium pyruvate. N1E-115 were grown in
DMEM supplemented with 10% fetal bovine serum, 25 U/ml penicil-
lin and 25 Wg/ml streptomycin.
2.3. Western blot
At 48 h post-transfection, cells were lysed in extraction bu¡er con-
taining a protease inhibitor cocktail (Boehringer). Equal amounts (30
Wg) of total cellular protein were loaded per well, size fractionated on
3^10% polyacrylamide/sodium dodecyl sulfate gels and transferred
onto nitrocellulose membrane (Gibco) as previously described [25].
Blots were incubated overnight in the presence of monoclonal anti-
dystrophin antibody, H5A3 (1:500) [26], and developed using the
ECL Western blotting analysis system (Amersham).
2.4. Transfection and confocal microscopy analysis
Cells plated on coverslips were transfected with 5 Wg of each GFP-
Dp71 construct pre-mixed with 5 Wl of Plus reagent and 8 Wl of lipo-
fectamine (Gibco) in serum free medium. After a 5 h incubation
period, the transfection mixture was removed by washing with
DMEM and cells were maintained in DMEM supplemented with
serum for 48 h. For phalloidin staining, cell were ¢xed in 3% para-
formaldehyde for 15 min at room temperature, permeabilized in 0.3%
Triton X-100 for 5 min and then incubated for 5 min with Texas Red-
phalloidin (Molecular Probes). After washing, coverslips were
mounted on microscope slides with VectaShield (Vector laboratories
Inc.). GFP and Texas Red staining were visualized on a Nikon epi-
£uorescence microscope coupled with a laser scanning confocal sys-
tem Bio-Rad MRC 600. From each image, 9^12 Z-sections (0.2^0.5
Wm tick) were taken starting from the top of the cell.
2.5. Flow cytometric analysis
At 48 h post-transfection, cells were removed from six well plates by
trypsin treatment, washed twice with phosphate-bu¡ered saline (PBS)
and resuspended in 500 Wl of PBS. Fluorescent emission of cells ex-
pressing GFP-Dp71 protein fusions was analyzed with a FACSort
(Becton Dickinson Immunocytometry System, San Jose¤, CA, USA)
using a 488^515 nm band pass ¢lter. Data were acquired and analyzed
with CellQuest software (Becton Dickinson).
3. Results
To determine the subcellular localization of Dp71 protein
isoforms, four di¡erent Dp71 cDNAs, alternatively spliced for
exons 71 and/or 78 [23], were fused with the 3P end of the
GFP gene (Fig. 1). GFP-Dp71 gene fusions are under the
control of the cytomegalovirus promoter. To examine the ex-
pression of the proteins synthesized from the hybrid genes,
human HeLa cells were transfected with each of the fusion
genes and equal aliquots of cell lysates were analyzed by
Western immunoblot using an anti-dystrophin monoclonal
antibody H5A3 which recognizes epitopes encoded by exons
73 and 74 [26]. Taking into account that GFP and Dp71 have
Fig. 1. Schematic illustration of the GFP-Dp71 gene fusion constructs. The cDNA sequences corresponding to Dp71 isoforms were fused to
the C-terminus of GFP. The alternatively spliced exons of Dp71 are denoted by breaks in the solid horizontal lines. The constructs contain the
cytomegalovirus promoter (CMV) and the polyadenylation signal (poly (A)) of BGH.
Fig. 2. Transient expression of the GFP-Dp71 protein fusions in
HeLa cells. Cell lysates from transfected HeLa cells were analyzed
48 h post-transfection by Western blotting using an anti-dystrophin
monoclonal antibody, H5A3. *, untransfected cells. The + and 3
symbols in brackets represent the presence or absence of exons 71
and/or 78, respectively. Numbers at the left denote protein molecu-
lar weight markers in kDa. The position of endogenous Dp71 and
GFP-DP71 fusion proteins is indicated at the right.
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Fig. 3. Subcellular localization of Dp71 spliced isoforms. Plasmid expression constructs encoding GFP-tagged Dp71 isoforms were transfected
into the cell lines indicated at the top of the ¢gure. The + and 3 symbols in brackets represent the presence or absence of exons 71 and/or 78,
respectively. Cells transfected with the construct GFP-Dp71 (3/+) were ¢xed and stained with Texas Red-phalloidin to visualize cytoplasmic ac-
tin. Images of representative cell ¢elds were captured 48 h post-transfection on an epi£uorescence confocal microscope.
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molecular weights of 28 and 70 kDa, respectively, the protein
fusions would have molecular masses of approximately 100
kDa. As shown in Fig. 2, a 70 kDa band that corresponds
to the endogenous Dp71 was observed in both transfected and
untransfected cells (lanes 1^5). Additionally, a fusion protein
band of the expected molecular mass was produced in sub-
stantial amount from each GFP-Dp71 plasmid (lanes 2^5).
No fusion protein band was detected in lysates from untrans-
fected cells, thereby demonstrating the speci¢city of the im-
munodetection. Also, these results demonstrated that the GFP
portion did not a¡ect the accumulation of the fusion proteins.
Next, to study the localization pattern of each GFP-Dp71
fusion protein in living cells, HeLa cells were transfected with
the di¡erent expression vectors and observed by confocal laser
scan microscopy. As a control, expression of GFP from the
plasmid pQBI25 was veri¢ed in parallel. As previously re-
ported [27], GFP protein alone was equally distributed be-
tween the cytoplasm and the nucleus (data not shown). Since
GFP has a molecular weight of 29 kDa, this protein is able to
enter the nucleus passively through the nuclear pore complex
(NPC). The Dp71 isoform lacking the amino acids encoded by
exons 71 and 78 (3/3) showed a punctuate labeling through-
out the cytoplasm with the cellular margins more intensely
stained (Fig. 3). The isoforms generated from constructs con-
taining exon 71 and exon 78 (+/+) or preserving exon 71 but
not exon 78 (+/3) showed a £uorescence accumulation in
both the cytoplasm and the nucleus (Fig. 3). Judging from
the contrast of £uorescence between the cytoplasm and the
nucleus, the distribution of these Dp71 variants seems to be
predominantly nuclear. The remaining isoform, lacking amino
acids encoded by exon 71 and preserving those encoded by
exon 78, localized exclusively to nuclei (Fig. 3).
To ascertain whether the subcellular localization of Dp71
variants is independent of species and/or cell type, we ana-
lyzed their pattern of distribution in two other cell lines of
di¡erent origin, C2C12, a mouse myogenic clone, and N1E-
115, a mouse neuroblastoma cell line. The protein localization
pattern of the Dp71 splicing variants was identical to that
found with HeLa cells: isoforms 3/3 and 3/+ showed exclu-
sive cytoplasmic and nuclear accumulation, respectively,
whereas the isoforms +/3 and +/+ presented the majority of
the signal in the nucleus with a comparative weak signal in the
cytoplasm (Fig. 3). These results indicate that the absence of
amino acids encoded by exons 71 and 78 confers a cytoplasm
distribution of Dp71 and that the presence of amino acids
encoded by exons 71 and/or 78 confers nuclear localization
on Dp71. Yet, the construct containing exon 78 solely has a
higher nuclear import e⁄ciency than those containing exon 71
or both, exon 71 and exon 78. To rule out the possibility that
the presence of the isoforms +/+ and +/3 in the cytoplasm is
due to the saturation of the nuclear import mechanism by
overproduction of these proteins, we determined the expres-
sion of each GFP-Dp71 gene fusion by £ow cytometric anal-
ysis. It was found that the mean intensities of £uorescence of
transformed cells were similar among the four fusion proteins
(Table 1).
4. Discussion
It has been established that Dp71 is alternatively spliced for
exons 71 and/or 78. The deletion of exon 71 does not change
the reading frame and therefore results in removal of 13 ami-
no acids from the protein. On the contrary, the absence of
exon 78 does change the reading frame replacing the last 13
amino acids with a hydrophobic C-terminus consisting of 31
unique residues [23]. Alternatively spliced transcripts of Dp71
are expressed at varying levels in a number of human adult
tissues [23]. At the protein level, the use of isoform-speci¢c
antibodies, that distinguish between the hydrophilic and the
hydrophobic C-termini, showed wide variation among tissues
in both the level of Dp71 expression and in the ratio of the
two C-terminus variants (P. Ray, unpublished results).
In this study, we analyzed the pattern of subcellular distri-
bution of GFP-tagged Dp71 isoforms alternatively spliced for
exon 71 and/or 78. We found that alternative splicing deter-
mines the subcellular localization of Dp71 in the HeLa,
C2C12 and N1E-115 cell lines. The isoform of Dp71 lacking
the amino acids encoded by exon 71 and exon 78 appeared to
be exclusively cytoplasmic, while an isoform generated from a
construct containing exon 78 but not exon 71 presented nu-
clear localization. The remaining two isoforms (+/3 and +/+)
showed predominant nuclear localization with a weak signal
in the cytoplasm. It seems that the presence of the amino acids
encoded by either exon 71 or 78 in the Dp71 protein changes
its cellular localization drastically from the cytoplasm to the
nucleus. Previous studies have shown that Dp71 is associated
with the plasma membrane of Hep2 cells and muscle tissue of
mdx mice [22,28]. Recently, Howard et al. [29] reported that
Dp71 localizes to stress ¢ber-like structures in myogenic cul-
tured cells. None of these studies reported the presence of
Dp71 in the nucleus. One possible explanation for this dis-
crepancy is that the GFP moiety mislocalized Dp71 to the
nucleus, however, this is unlikely since the size of GFP-
Dp71 fusion proteins (100 kDa) is well above the exclusion
limit of the NPC (6 40 kDa). Therefore, without a speci¢c
transport mechanism through the NPC, the fusion proteins
would be excluded from the nucleus [30,31], instead, we ob-
served a nuclear accumulation of GFP-Dp71 isoforms con-
taining the protein domains encoded by exon 71 and/or 78.
In support of these results, it has been found that the endog-
enous Dp71, expressed in PC12 cells, shows a predominant
nuclear localization when it is derived from transcripts con-
taining exon 78 and a cytoplasmic localization when it is
generated from transcripts alternatively spliced for exon 78
(F. Marquez et al., article in preparation). Nuclear localiza-
tion of Dp71 does not seem to be a restricted phenomenon
present only in certain cell types, since it was observed in the
three cell lines studied.
Our data suggest the existence of a pathway that allows
Dp71 to migrate into the nucleus by an active transport
through the NPC. Selective nuclear import requires energy,
physiological temperature, a nuclear localizing signal (NLS)
and soluble transport machinery [30,31]. Two of the best char-
Table 1
Quanti¢cation of GFP-Dp71 gene fusions expression using FACS
analysis
Int Subcellular localization
GFP-Dp71 (3/+) 26.94 þ 2.55 N
GFP-Dp71 (+/3) 26.54 þ 2.10 N/C
GFP-Dp71 (+/+) 27.56 þ 2.36 N/C
GFP-Dp71 (3/3) 28.43 þ 2.97 C
Int denotes the mean þ S.D. of £uorescence intensity. N, nuclear lo-
calization; C, cytoplasmic localization.
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acterized NLS motifs are the simian virus 40 large T-antigen
NLS (also known as the classical NLS) and the nucleoplasmin
bipartite NLS. The classical NLS contains a stretch of basic
amino acids whereas the bipartite NLS is composed of two
basic stretches separated by a sequence of 10^12 amino acids
[30]. A protein carrying the classical or the bipartite NLS is
bound by a cytoplasmic receptor that consists of importins K
and L. Importin K serves as adaptor able to bridge the binding
between proteins carrying di¡erent NLS sequences and impor-
tin L. Importin L targets the complex to the NPC and the
complex is then translocated into the nucleus. Upon entering
the nucleus, the complex is dissociated by binding of Ran-
GTP to importin L [30,31].
According to our results, it could be proposed that two
di¡erent NLSs are present in Dp71, the strongest one in the
protein domain encoded by exon 78 and the other one within
the stretch of amino acids encoded by exon 71. A computa-
tional analysis of the entire amino acid sequence of Dp71
failed to detect a consensus NLS motif, nevertheless, it is
possible that the Dp71 protein sequence contains atypical
NLS motifs. Previously, several examples of proteins with
NLS sequences that do not conform to the classical NLS
have been identi¢ed including the HIV-I Tat protein [32],
the heat shock protein Hsp70 [33] and the cell adhesion and
signaling protein L-catenin [34]. Nuclear import of the ¢rst
two proteins is believed to occur by a novel mechanism dis-
tinct from that mediated by importins, whereas the nuclear
translocation of L-catenin is facilitated by its direct interaction
with the nuclear pore proteins [32^34]. Alternatively, it could
be possible that Dp71 enters into the nucleus through its
association with other proteins that facilitate its access to
the soluble transport machinery, as reported for a number
of nuclear proteins [30]. Further studies are necessary to un-
equivocally establish the presence of at least one active NLS
in the protein sequence of Dp71.
Protein import into the nucleus has several levels of regu-
lation, one of which is protein phosphorylation. Phosphory-
lation can induce nuclear translocation by releasing the cargo
from a cytoplasmic anchor or by promoting the association of
the cargo with its import receptor [30]. Protein phosphoryla-
tion can also inhibit nuclear import by inducing an intramo-
lecular change that masks the NLS sequence or by decreasing
the a⁄nity of the cargo for its import receptor [30]. In this
respect, it has been shown that dystrophin is phosphorylated
at serine and threonine residues by endogenous protein ki-
nases [35,36] although the exact sites have not yet been
mapped. Likewise, Dp71 was found to be phosphorylated in
skeletal muscle of mdx mice transgenic for Dp71 [22]. Se-
quence analysis of Dp71 revealed two potential phosphoryla-
tion sites in the C-terminal region, the ¢rst located in exon 78
and the second in exon 79 [35,36]. Therefore, it is interesting
to speculate that nuclear import of Dp71 isoforms, generated
from transcripts bearing exon 78, is modulated by means of
phosphorylation.
While it is di⁄cult to envisage a role for Dp71 in the nu-
cleus, it should be emphasized that a member of the DAPC
complex, L-dystrobrevin and the recently characterized syn-
trophin-binding protein, SAT (syntrophin-associated serine/
threonine kinase) have been found in the nuclei of hippocam-
pal pyramidal neurons [19,37]. Hence, our data and the data
of other authors raise the possibility that a DPC-like complex
may be present in the nucleus. Clearly, establishing a role for
these proteins in the nucleus warrants further investigation.
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